Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies (Q36178344)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

meta-analysis

0 references

review article

1 reference

stated in

Europe PubMed Central

title

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

main subject

meta-analysis

1 reference

based on heuristic

inferred from title

bone fracture

1 reference

based on heuristic

inferred from title

author name string

Steven Boonen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

Roland F Laan

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

Ian P Barton

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

Nelson B Watts

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

language of work or name

English

0 references

publication date

29 June 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

published in

Osteoporosis International

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

volume

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

page(s)

1291-1298

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

cites work

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00198-005-1945-X

retrieved

21 January 2018

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Food and Drug Administration's Osteoporosis Guidance Document: past, present, and future

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A model of lifetime osteoporosis impact.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICH E9 guideline 'Statistical principles for clinical trials': a case study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15986101

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00198-005-1945-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

PubMed publication ID

15986101

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15986101

retrieved

12 August 2017

ResearchGate publication ID

7758034

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36178344&oldid=2198303890"